Mutlu, H. Et Al. 2014. The Necessity of Cytoreductive Nephrectomy in Patients With Metastatic Renal Cell Carcinoma Using Antiangiogenic Targeted Therapy After Interferon Alfa-2b. CLINICAL GENITOURINARY CANCER , vol.12, no.6 , 447-450.

Mutlu, H., Gunduz, S., Buyukcelik, A., Yildiz, O., Uysal, M., Tural, D., ... Bozcuk, H.(2014). The Necessity of Cytoreductive Nephrectomy in Patients With Metastatic Renal Cell Carcinoma Using Antiangiogenic Targeted Therapy After Interferon Alfa-2b. CLINICAL GENITOURINARY CANCER , vol.12, no.6, 447-450.

Mutlu, HASAN Et Al. "The Necessity of Cytoreductive Nephrectomy in Patients With Metastatic Renal Cell Carcinoma Using Antiangiogenic Targeted Therapy After Interferon Alfa-2b," CLINICAL GENITOURINARY CANCER , vol.12, no.6, 447-450, 2014

Mutlu, HASAN Et Al. "The Necessity of Cytoreductive Nephrectomy in Patients With Metastatic Renal Cell Carcinoma Using Antiangiogenic Targeted Therapy After Interferon Alfa-2b." CLINICAL GENITOURINARY CANCER , vol.12, no.6, pp.447-450, 2014

Mutlu, H. Et Al. (2014) . "The Necessity of Cytoreductive Nephrectomy in Patients With Metastatic Renal Cell Carcinoma Using Antiangiogenic Targeted Therapy After Interferon Alfa-2b." CLINICAL GENITOURINARY CANCER , vol.12, no.6, pp.447-450.

@article{article, author={HASAN MUTLU Et Al. }, title={The Necessity of Cytoreductive Nephrectomy in Patients With Metastatic Renal Cell Carcinoma Using Antiangiogenic Targeted Therapy After Interferon Alfa-2b}, journal={CLINICAL GENITOURINARY CANCER}, year=2014, pages={447-450} }